FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3147504414> ?p ?o ?g. }

• W3147504414 endingPage "175394472110026" @default.
• W3147504414 startingPage "175394472110026" @default.
• W3147504414 abstract "Sodium-glucose cotransporter type 2 (SGLT2) inhibitors are a relatively new class of antihyperglycemic drug with salutary effects on glucose control, body weight, and blood pressure. Emerging evidence now indicates that these drugs may have a beneficial effect on outcomes in heart failure with reduced ejection fraction (HFrEF). Post-approval cardiovascular outcomes data for three of these agents (canagliflozin, empagliflozin, and dapagliflozin) showed an unexpected improvement in cardiovascular endpoints, including heart failure hospitalization and mortality, among patients with type 2 diabetes mellitus (T2DM) and established cardiovascular disease or risk factors. These studies were followed by a placebo controlled trial of dapagliflozin in patients with HFrEF both with and without T2DM, showing a reduction in all-cause mortality comparable to current guideline-directed HFrEF medical therapies such as angiotensin-converting enzyme inhibitors and beta-blockers. In this review, we discuss the current landscape of evidence, safety and adverse effects, and proposed mechanisms of action for use of these agents for patients with HFrEF. The United States (US) and European guidelines are reviewed, as are the current US federally approved indications for each SGLT2 inhibitor. Use of these agents in clinical practice may be limited by an uncertain insurance environment, especially in patients without T2DM. Finally, we discuss practical considerations for the cardiovascular clinician, including within-class differences of the SGLT2 inhibitors currently available on the US market (217/300)." @default.
• W3147504414 created "2021-04-13" @default.
• W3147504414 creator A5045710404 @default.
• W3147504414 creator A5051784315 @default.
• W3147504414 date "2021-01-01" @default.
• W3147504414 modified "2023-09-25" @default.
• W3147504414 title "The dawn of the four-drug era? SGLT2 inhibition in heart failure with reduced ejection fraction" @default.
• W3147504414 cites W1484764833 @default.
• W3147504414 cites W1966182783 @default.
• W3147504414 cites W1969817339 @default.
• W3147504414 cites W1993812967 @default.
• W3147504414 cites W1998453182 @default.
• W3147504414 cites W2008443217 @default.
• W3147504414 cites W2076506641 @default.
• W3147504414 cites W2086860898 @default.
• W3147504414 cites W2093350841 @default.
• W3147504414 cites W2113698123 @default.
• W3147504414 cites W2132469735 @default.
• W3147504414 cites W2133469996 @default.
• W3147504414 cites W2134304394 @default.
• W3147504414 cites W2146264128 @default.
• W3147504414 cites W2151345870 @default.
• W3147504414 cites W2152211669 @default.
• W3147504414 cites W2156587192 @default.
• W3147504414 cites W2168817129 @default.
• W3147504414 cites W2202866687 @default.
• W3147504414 cites W2223344044 @default.
• W3147504414 cites W2232883894 @default.
• W3147504414 cites W2323458614 @default.
• W3147504414 cites W2326508838 @default.
• W3147504414 cites W2553261268 @default.
• W3147504414 cites W2562743482 @default.
• W3147504414 cites W2572360735 @default.
• W3147504414 cites W2625462710 @default.
• W3147504414 cites W2626446274 @default.
• W3147504414 cites W2744509403 @default.
• W3147504414 cites W2758676322 @default.
• W3147504414 cites W2760952310 @default.
• W3147504414 cites W2763866789 @default.
• W3147504414 cites W2768576350 @default.
• W3147504414 cites W2772835527 @default.
• W3147504414 cites W2782103987 @default.
• W3147504414 cites W2796197883 @default.
• W3147504414 cites W2883722299 @default.
• W3147504414 cites W2890465901 @default.
• W3147504414 cites W2892498615 @default.
• W3147504414 cites W2895561864 @default.
• W3147504414 cites W2900413769 @default.
• W3147504414 cites W2901952910 @default.
• W3147504414 cites W2911336471 @default.
• W3147504414 cites W2921866736 @default.
• W3147504414 cites W2939048096 @default.
• W3147504414 cites W2944225896 @default.
• W3147504414 cites W2944568480 @default.
• W3147504414 cites W2945994263 @default.
• W3147504414 cites W2965056983 @default.
• W3147504414 cites W2974260792 @default.
• W3147504414 cites W2984766121 @default.
• W3147504414 cites W3000967053 @default.
• W3147504414 cites W3013838418 @default.
• W3147504414 cites W3022116511 @default.
• W3147504414 cites W3081830235 @default.
• W3147504414 cites W3093027350 @default.
• W3147504414 cites W4206159607 @default.
• W3147504414 cites W4211150832 @default.
• W3147504414 cites W4238907867 @default.
• W3147504414 cites W4293085726 @default.
• W3147504414 cites W4293860347 @default.
• W3147504414 cites W52877415 @default.
• W3147504414 cites W2953055087 @default.
• W3147504414 doi "https://doi.org/10.1177/17539447211002678" @default.
• W3147504414 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8010852" @default.
• W3147504414 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33779401" @default.
• W3147504414 hasPublicationYear "2021" @default.
• W3147504414 type Work @default.
• W3147504414 sameAs 3147504414 @default.
• W3147504414 citedByCount "10" @default.
• W3147504414 countsByYear W31475044142021 @default.
• W3147504414 countsByYear W31475044142022 @default.
• W3147504414 countsByYear W31475044142023 @default.
• W3147504414 crossrefType "journal-article" @default.
• W3147504414 hasAuthorship W3147504414A5045710404 @default.
• W3147504414 hasAuthorship W3147504414A5051784315 @default.
• W3147504414 hasBestOaLocation W31475044141 @default.
• W3147504414 hasConcept C126322002 @default.
• W3147504414 hasConcept C134018914 @default.
• W3147504414 hasConcept C142724271 @default.
• W3147504414 hasConcept C164705383 @default.
• W3147504414 hasConcept C177713679 @default.
• W3147504414 hasConcept C197934379 @default.
• W3147504414 hasConcept C204787440 @default.
• W3147504414 hasConcept C27081682 @default.
• W3147504414 hasConcept C2775887513 @default.
• W3147504414 hasConcept C2777422806 @default.
• W3147504414 hasConcept C2777451236 @default.
• W3147504414 hasConcept C2778176773 @default.
• W3147504414 hasConcept C2778198053 @default.
• W3147504414 hasConcept C2780035454 @default.

• next